{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:23:32Z","timestamp":1792797812572,"version":"4.5.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100009408","name":"Fondation Brain Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009408","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Gouvernement du Canada | Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["518155"],"award-info":[{"award-number":["518155"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000038","name":"Gouvernement du Canada | Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","award":["RGPIN-2023-03659"],"award-info":[{"award-number":["RGPIN-2023-03659"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000261","name":"Multiple Sclerosis Society of Canada","doi-asserted-by":"publisher","award":["1019973"],"award-info":[{"award-number":["1019973"]}],"id":[{"id":"10.13039\/501100000261","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Saskatchewan Health Research Foundation University of Saskatchewan College of Medicine","id":[{"id":"https:\/\/ror.org\/010x8gc63","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Neurosci"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1038\/s41593-025-02113-y","type":"journal-article","created":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T10:02:39Z","timestamp":1764583359000},"page":"67-80","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Oxidized phosphatidylcholines deposition drives chronic neurodegeneration in a mouse model of progressive multiple sclerosis via IL-1\u03b2 signaling"],"prefix":"10.1038","volume":"29","author":[{"given":"Ruoqi","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0940-0169","authenticated-orcid":false,"given":"Brian M.","family":"Lozinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ally","family":"Seifert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khanh","family":"Ta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0812-676X","authenticated-orcid":false,"given":"Stephanie","family":"Zandee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0199-5321","authenticated-orcid":false,"given":"Deepak K.","family":"Kaushik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Klement","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Larouche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sotirios","family":"Tsimikas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph L.","family":"Witztum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9568-545X","authenticated-orcid":false,"given":"Dorian B.","family":"McGavern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6188-0580","authenticated-orcid":false,"given":"Alexandre","family":"Prat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1483-2046","authenticated-orcid":false,"given":"Yifei","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,1]]},"reference":[{"key":"2113_CR1","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41582-021-00581-x","volume":"18","author":"HYF Yong","year":"2022","unstructured":"Yong, H. Y. F. & Yong, V. W. Mechanism-based criteria to improve therapeutic outcomes in progressive multiple sclerosis. Nat. Rev. Neurol. 18, 40\u201355 (2022).","journal-title":"Nat. Rev. Neurol."},{"key":"2113_CR2","doi-asserted-by":"crossref","unstructured":"University of California, San Francisco MS-EPIC Team et al. Silent progression in disease activity-free relapsing multiple sclerosis. Ann. Neurol. 85, 653\u2013666 (2019).","DOI":"10.1002\/ana.25463"},{"key":"2113_CR3","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1093\/brain\/awac111","volume":"145","author":"E Portaccio","year":"2022","unstructured":"Portaccio, E. et al. Progression is independent of relapse activity in early multiple sclerosis: a real-life cohort study. Brain 145, 2796\u20132805 (2022).","journal-title":"Brain"},{"key":"2113_CR4","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1093\/brain\/awac016","volume":"145","author":"FD Lublin","year":"2022","unstructured":"Lublin, F. D. et al. How patients with multiple sclerosis acquire disability. Brain 145, 3147\u20133161 (2022).","journal-title":"Brain"},{"key":"2113_CR5","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1136\/jnnp.2010.208173","volume":"81","author":"M Koch","year":"2010","unstructured":"Koch, M., Kingwell, E., Rieckmann, P., Tremlett, H. & Neurologists, U. M. C. The natural history of secondary progressive multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 81, 1039\u20131043 (2010).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"2113_CR6","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1002\/ana.24497","volume":"78","author":"JM Frischer","year":"2015","unstructured":"Frischer, J. M. et al. Clinical and pathological insights into the dynamic nature of the white matter multiple sclerosis plaque. Ann. Neurol. 78, 710\u2013721 (2015).","journal-title":"Ann. Neurol."},{"key":"2113_CR7","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/s41586-021-03892-7","volume":"597","author":"M Absinta","year":"2021","unstructured":"Absinta, M. et al. A lymphocyte\u2013microglia\u2013astrocyte axis in chronic active multiple sclerosis. Nature 597, 709\u2013714 (2021).","journal-title":"Nature"},{"key":"2113_CR8","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1177\/1352458518814117","volume":"25","author":"C Elliott","year":"2019","unstructured":"Elliott, C. et al. Slowly expanding\/evolving lesions as a magnetic resonance imaging marker of chronic active multiple sclerosis lesions. Mult. Scler. J. 25, 1915\u20131925 (2019).","journal-title":"Mult. Scler. J."},{"key":"2113_CR9","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s00401-018-1818-y","volume":"135","author":"S Luchetti","year":"2018","unstructured":"Luchetti, S. et al. Progressive multiple sclerosis patients show substantial lesion activity that correlates with clinical disease severity and sex: a retrospective autopsy cohort analysis. Acta Neuropathol. 135, 511\u2013528 (2018).","journal-title":"Acta Neuropathol."},{"key":"2113_CR10","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00401-020-02189-9","volume":"140","author":"K Hess","year":"2020","unstructured":"Hess, K. et al. Lesion stage-dependent causes for impaired remyelination in MS. Acta Neuropathol. 140, 359\u2013375 (2020).","journal-title":"Acta Neuropathol."},{"key":"2113_CR11","first-page":"137ra173","volume":"4","author":"PP Ho","year":"2012","unstructured":"Ho, P. P. et al. Identification of naturally occurring fatty acids of the myelin sheath that resolve neuroinflammation. Sci. Transl. Med. 4, 137ra173 (2012).","journal-title":"Sci. Transl. Med."},{"key":"2113_CR12","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/nm1344","volume":"12","author":"JL Kanter","year":"2006","unstructured":"Kanter, J. L. et al. Lipid microarrays identify key mediators of autoimmune brain inflammation. Nat. Med. 12, 138\u2013143 (2006).","journal-title":"Nat. Med."},{"key":"2113_CR13","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1093\/brain\/awr128","volume":"134","author":"L Haider","year":"2011","unstructured":"Haider, L. et al. Oxidative damage in multiple sclerosis lesions. Brain 134, 1914\u20131924 (2011).","journal-title":"Brain"},{"key":"2113_CR14","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.bbadis.2015.09.018","volume":"1862","author":"H Lassmann","year":"2016","unstructured":"Lassmann, H. & van Horssen, J. Oxidative stress and its impact on neurons and glia in multiple sclerosis lesions. Biochim. Biophys. Acta 1862, 506\u2013510 (2016).","journal-title":"Biochim. Biophys. Acta"},{"key":"2113_CR15","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00401-014-1263-5","volume":"128","author":"C Schuh","year":"2014","unstructured":"Schuh, C. et al. Oxidative tissue injury in multiple sclerosis is only partly reflected in experimental disease models. Acta Neuropathol. 128, 247\u2013266 (2014).","journal-title":"Acta Neuropathol."},{"key":"2113_CR16","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1093\/brain\/awt110","volume":"136","author":"MT Fischer","year":"2013","unstructured":"Fischer, M. T. et al. Disease-specific molecular events in cortical multiple sclerosis lesions. Brain 136, 1799\u20131815 (2013).","journal-title":"Brain"},{"key":"2113_CR17","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1002\/ana.23974","volume":"74","author":"S Hametner","year":"2013","unstructured":"Hametner, S. et al. Iron and neurodegeneration in the multiple sclerosis brain. Ann. Neurol. 74, 848\u2013861 (2013).","journal-title":"Ann. Neurol."},{"key":"2113_CR18","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1136\/jnnp-2014-307712","volume":"85","author":"L Haider","year":"2014","unstructured":"Haider, L. et al. Multiple sclerosis deep grey matter: the relation between demyelination, neurodegeneration, inflammation and iron. J. Neurol. Neurosurg. Psychiatry 85, 1386\u20131395 (2014).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"2113_CR19","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s00401-016-1636-z","volume":"133","author":"A Dal-Bianco","year":"2017","unstructured":"Dal-Bianco, A. et al. Slow expansion of multiple sclerosis iron rim lesions: pathology and 7 T magnetic resonance imaging. Acta Neuropathol. 133, 25\u201342 (2017).","journal-title":"Acta Neuropathol."},{"key":"2113_CR20","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1093\/brain\/awaa158","volume":"143","author":"K Jackle","year":"2020","unstructured":"Jackle, K. et al. Molecular signature of slowly expanding lesions in progressive multiple sclerosis. Brain 143, 2073\u20132088 (2020).","journal-title":"Brain"},{"key":"2113_CR21","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1093\/brain\/aws012","volume":"135","author":"MT Fischer","year":"2012","unstructured":"Fischer, M. T. et al. NADPH oxidase expression in active multiple sclerosis lesions in relation to oxidative tissue damage and mitochondrial injury. Brain 135, 886\u2013899 (2012).","journal-title":"Brain"},{"key":"2113_CR22","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/s41593-021-00801-z","volume":"24","author":"Y Dong","year":"2021","unstructured":"Dong, Y. et al. Oxidized phosphatidylcholines found in multiple sclerosis lesions mediate neurodegeneration and are neutralized by microglia. Nat. Neurosci. 24, 489\u2013503 (2021).","journal-title":"Nat. Neurosci."},{"key":"2113_CR23","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/s43587-022-00205-z","volume":"2","author":"Y Dong","year":"2022","unstructured":"Dong, Y. et al. Single-cell and spatial RNA sequencing identify perturbators of microglial functions with aging. Nat. Aging 2, 508\u2013525 (2022).","journal-title":"Nat. Aging"},{"key":"2113_CR24","doi-asserted-by":"crossref","first-page":"4725","DOI":"10.1523\/JNEUROSCI.2312-22.2023","volume":"43","author":"S Xue","year":"2023","unstructured":"Xue, S. et al. Elevated galectin-3 is associated with aging, multiple sclerosis, and oxidized phosphatidylcholine-induced neurodegeneration. J. Neurosci. 43, 4725\u20134737 (2023).","journal-title":"J. Neurosci."},{"key":"2113_CR25","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/s41586-018-0198-8","volume":"558","author":"X Que","year":"2018","unstructured":"Que, X. et al. Oxidized phospholipids are proinflammatory and proatherogenic in hypercholesterolaemic mice. Nature 558, 301\u2013306 (2018).","journal-title":"Nature"},{"key":"2113_CR26","doi-asserted-by":"crossref","unstructured":"Sun, X. et al. Neutralization of oxidized phospholipids ameliorates non-alcoholic steatohepatitis. Cell Metab. 31, 189\u2013206 (2019).","DOI":"10.1016\/j.cmet.2019.10.014"},{"key":"2113_CR27","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00401-016-1631-4","volume":"133","author":"H Lassmann","year":"2017","unstructured":"Lassmann, H. & Bradl, M. Multiple sclerosis: experimental models and reality. Acta Neuropathol. 133, 223\u2013244 (2017).","journal-title":"Acta Neuropathol."},{"key":"2113_CR28","doi-asserted-by":"crossref","first-page":"14290","DOI":"10.1073\/pnas.1819343116","volume":"116","author":"M Baydyuk","year":"2019","unstructured":"Baydyuk, M. et al. Tracking the evolution of CNS remyelinating lesion in mice with neutral red dye. Proc. Natl Acad. Sci. USA 116, 14290\u201314299 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2113_CR29","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.bbadis.2010.09.010","volume":"1812","author":"VE Miron","year":"2011","unstructured":"Miron, V. E., Kuhlmann, T. & Antel, J. P. Cells of the oligodendroglial lineage, myelination, and remyelination. Biochim. Biophys. Acta 1812, 184\u2013193 (2011).","journal-title":"Biochim. Biophys. Acta"},{"key":"2113_CR30","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0304-3940(93)90398-5","volume":"160","author":"SM Gentleman","year":"1993","unstructured":"Gentleman, S. M., Nash, M. J., Sweeting, C. J., Graham, D. I. & Roberts, G. W. Beta-amyloid precursor protein (beta APP) as a marker for axonal injury after head injury. Neurosci. Lett. 160, 139\u2013144 (1993).","journal-title":"Neurosci. Lett."},{"key":"2113_CR31","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.neuron.2022.10.028","volume":"111","author":"X Wang","year":"2023","unstructured":"Wang, X. et al. Driving axon regeneration by orchestrating neuronal and non-neuronal innate immune responses via the IFN\u03b3\u2013cGAS\u2013STING axis. Neuron 111, 236\u2013255 (2023).","journal-title":"Neuron"},{"key":"2113_CR32","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1038\/s41593-024-01796-z","volume":"27","author":"C Lerma-Martin","year":"2024","unstructured":"Lerma-Martin, C. et al. Cell type mapping reveals tissue niches and interactions in subcortical multiple sclerosis lesions. Nat. Neurosci. 27, 2354\u20132365 (2024).","journal-title":"Nat. Neurosci."},{"key":"2113_CR33","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/s41587-020-0739-1","volume":"39","author":"RR Stickels","year":"2021","unstructured":"Stickels, R. R. et al. Highly sensitive spatial transcriptomics at near-cellular resolution with Slide-seqV2. Nat. Biotechnol. 39, 313\u2013319 (2021).","journal-title":"Nat. Biotechnol."},{"key":"2113_CR34","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.immuni.2017.08.008","volume":"47","author":"S Krasemann","year":"2017","unstructured":"Krasemann, S. et al. The TREM2\u2013APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases. Immunity 47, 566\u2013581 (2017).","journal-title":"Immunity"},{"key":"2113_CR35","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1093\/brain\/awaa098","volume":"143","author":"AR Gafson","year":"2020","unstructured":"Gafson, A. R. et al. Neurofilaments: neurobiological foundations for biomarker applications. Brain 143, 1975\u20131998 (2020).","journal-title":"Brain"},{"key":"2113_CR36","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.cell.2013.07.037","volume":"154","author":"BH Toyama","year":"2013","unstructured":"Toyama, B. H. et al. Identification of long-lived proteins reveals exceptional stability of essential cellular structures. Cell 154, 971\u2013982 (2013).","journal-title":"Cell"},{"key":"2113_CR37","doi-asserted-by":"crossref","first-page":"3534","DOI":"10.1016\/j.neuron.2022.06.023","volume":"110","author":"VW Yong","year":"2022","unstructured":"Yong, V. W. Microglia in multiple sclerosis: protectors turn destroyers. Neuron 110, 3534\u20133548 (2022).","journal-title":"Neuron"},{"key":"2113_CR38","doi-asserted-by":"crossref","unstructured":"Plemel, J. R. et al. Microglia response following acute demyelination is heterogeneous and limits infiltrating macrophage dispersion. Sci. Adv. 6, eaay6324 (2020).","DOI":"10.1126\/sciadv.aay6324"},{"key":"2113_CR39","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1093\/jnen\/nlab083","volume":"80","author":"JW Prineas","year":"2021","unstructured":"Prineas, J. W. & Parratt, J. D. E. Multiple sclerosis: microglia, monocytes, and macrophage-mediated demyelination. J. Neuropathol. Exp. Neurol. 80, 975\u2013996 (2021).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"2113_CR40","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.113031","volume":"42","author":"TE Faust","year":"2023","unstructured":"Faust, T. E. et al. A comparative analysis of microglial inducible Cre lines. Cell Rep. 42, 113031 (2023).","journal-title":"Cell Rep."},{"key":"2113_CR41","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41582-019-0244-7","volume":"15","author":"Y Hou","year":"2019","unstructured":"Hou, Y. et al. Ageing as a risk factor for neurodegenerative disease. Nat. Rev. Neurol. 15, 565\u2013581 (2019).","journal-title":"Nat. Rev. Neurol."},{"key":"2113_CR42","doi-asserted-by":"crossref","unstructured":"Matsudaira, T. et al. Cellular senescence in white matter microglia is induced during ageing in mice and exacerbates the neuroinflammatory phenotype. Commun. Biol. 6, 665 (2023).","DOI":"10.1038\/s42003-023-05027-2"},{"key":"2113_CR43","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/j.immuni.2022.07.004","volume":"55","author":"A Silvin","year":"2022","unstructured":"Silvin, A. et al. Dual ontogeny of disease-associated microglia and disease inflammatory macrophages in aging and neurodegeneration. Immunity 55, 1448\u20131465.e6 (2022).","journal-title":"Immunity"},{"key":"2113_CR44","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-05929-4","volume":"9","author":"SJ Rubino","year":"2018","unstructured":"Rubino, S. J. et al. Acute microglia ablation induces neurodegeneration in the somatosensory system. Nat. Commun. 9, 4578 (2018).","journal-title":"Nat. Commun."},{"key":"2113_CR45","doi-asserted-by":"crossref","first-page":"3874","DOI":"10.1038\/s41467-022-31562-3","volume":"13","author":"JY Peng","year":"2022","unstructured":"Peng, J. Y., Zou, Q., Chen, M. J., Ma, C. L. & Li, B. M. Motor deficits seen in microglial ablation mice could be due to non-specific damage from high dose diphtheria toxin treatment. Nat. Commun. 13, 3874 (2022).","journal-title":"Nat. Commun."},{"key":"2113_CR46","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.neuron.2014.02.040","volume":"82","author":"MR Elmore","year":"2014","unstructured":"Elmore, M. R. et al. Colony-stimulating factor 1 receptor signaling is necessary for microglia viability, unmasking a microglia progenitor cell in the adult brain. Neuron 82, 380\u2013397 (2014).","journal-title":"Neuron"},{"key":"2113_CR47","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/s41590-019-0539-2","volume":"21","author":"M Di Gioia","year":"2020","unstructured":"Di Gioia, M. et al. Endogenous oxidized phospholipids reprogram cellular metabolism and boost hyperinflammation. Nat. Immunol. 21, 42\u201353 (2020).","journal-title":"Nat. Immunol."},{"key":"2113_CR48","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nature10558","volume":"479","author":"N Kayagaki","year":"2011","unstructured":"Kayagaki, N. et al. Non-canonical inflammasome activation targets caspase-11. Nature 479, 117\u2013121 (2011).","journal-title":"Nature"},{"key":"2113_CR49","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1126\/science.7535475","volume":"267","author":"K Kuida","year":"1995","unstructured":"Kuida, K. et al. Altered cytokine export and apoptosis in mice deficient in interleukin-1 beta converting enzyme. Science 267, 2000\u20132003 (1995).","journal-title":"Science"},{"key":"2113_CR50","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/imr.12621","volume":"281","author":"CA Dinarello","year":"2018","unstructured":"Dinarello, C. A. Overview of the IL-1 family in innate inflammation and acquired immunity. Immunol. Rev. 281, 8\u201327 (2018).","journal-title":"Immunol. Rev."},{"key":"2113_CR51","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.immuni.2018.12.012","volume":"50","author":"X Liu","year":"2019","unstructured":"Liu, X. et al. Cell-type-specific interleukin 1 receptor 1 signaling in the brain regulates distinct neuroimmune activities. Immunity 50, 317\u2013333 (2019).","journal-title":"Immunity"},{"key":"2113_CR52","doi-asserted-by":"crossref","unstructured":"O\u2019Donnell, V. B., Aldrovandi, M., Murphy, R. C. & Kronke, G. Enzymatically oxidized phospholipids assume center stage as essential regulators of innate immunity and cell death. Sci. Signal 12, eaau2293 (2019).","DOI":"10.1126\/scisignal.aau2293"},{"key":"2113_CR53","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jneuroim.2018.10.009","volume":"325","author":"B Safizadeh","year":"2018","unstructured":"Safizadeh, B. et al. The role of expression and activity of 15-lipoxygenase isoforms and related cytokines in patients with multiple sclerosis and healthy controls. J. Neuroimmunol. 325, 32\u201342 (2018).","journal-title":"J. Neuroimmunol."},{"key":"2113_CR54","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/cvr\/cvy136","volume":"115","author":"C Yeang","year":"2019","unstructured":"Yeang, C. et al. Reduction of myocardial ischaemia\u2013reperfusion injury by inactivating oxidized phospholipids. Cardiovasc. Res. 115, 179\u2013189 (2019).","journal-title":"Cardiovasc. Res."},{"key":"2113_CR55","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1093\/brain\/awx113","volume":"140","author":"T Zrzavy","year":"2017","unstructured":"Zrzavy, T. et al. Loss of \u2018homeostatic\u2019 microglia and patterns of their activation in active multiple sclerosis. Brain 140, 1900\u20131913 (2017).","journal-title":"Brain"},{"key":"2113_CR56","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1126\/science.aan4183","volume":"359","author":"L Cantuti-Castelvetri","year":"2018","unstructured":"Cantuti-Castelvetri, L. et al. Defective cholesterol clearance limits remyelination in the aged central nervous system. Science 359, 684\u2013688 (2018).","journal-title":"Science"},{"key":"2113_CR57","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00401-016-1653-y","volume":"133","author":"T Kuhlmann","year":"2017","unstructured":"Kuhlmann, T. et al. An updated histological classification system for multiple sclerosis lesions. Acta Neuropathol. 133, 13\u201324 (2017).","journal-title":"Acta Neuropathol."},{"key":"2113_CR58","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/s41423-018-0198-5","volume":"16","author":"T Dhaeze","year":"2019","unstructured":"Dhaeze, T. et al. CD70 defines a subset of proinflammatory and CNS-pathogenic TH1\/TH17 lymphocytes and is overexpressed in multiple sclerosis. Cell Mol. Immunol. 16, 652\u2013665 (2019).","journal-title":"Cell Mol. Immunol."},{"key":"2113_CR59","doi-asserted-by":"crossref","unstructured":"Broux, B. et al. Interleukin-26, preferentially produced by TH17 lymphocytes, regulates CNS barrier function. Neurol. Neuroimmunol. Neuroinflamm. 7, e870 (2020).","DOI":"10.1212\/NXI.0000000000000870"},{"key":"2113_CR60","doi-asserted-by":"publisher","unstructured":"Kim, Y.-J. et al. Tutorial: guidelines for manual cell type annotation of single-cell multi-omics datasets using interactive software. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2023.07.11.548639 (2023).","DOI":"10.1101\/2023.07.11.548639"},{"key":"2113_CR61","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41587-023-01767-y","volume":"42","author":"Y Hao","year":"2024","unstructured":"Hao, Y. et al. Dictionary learning for integrative, multimodal and scalable single-cell analysis. Nat. Biotechnol. 42, 293\u2013304 (2024).","journal-title":"Nat. Biotechnol."},{"key":"2113_CR62","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/s41587-021-00830-w","volume":"40","author":"DM Cable","year":"2022","unstructured":"Cable, D. M. et al. Robust decomposition of cell type mixtures in spatial transcriptomics. Nat. Biotechnol. 40, 517\u2013526 (2022).","journal-title":"Nat. Biotechnol."},{"key":"2113_CR63","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/bioinformatics\/btt703","volume":"30","author":"A Kramer","year":"2014","unstructured":"Kramer, A., Green, J., Pollard, J. Jr & Tugendreich, S. Causal analysis approaches in Ingenuity Pathway Analysis. Bioinformatics 30, 523\u2013530 (2014).","journal-title":"Bioinformatics"}],"container-title":["Nature Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41593-025-02113-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41593-025-02113-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41593-025-02113-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T14:33:00Z","timestamp":1767796380000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41593-025-02113-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,1]]},"references-count":63,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["2113"],"URL":"https:\/\/doi.org\/10.1038\/s41593-025-02113-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4792293\/v1","asserted-by":"object"}]},"ISSN":["1097-6256","1546-1726"],"issn-type":[{"value":"1097-6256","type":"print"},{"value":"1546-1726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,1]]},"assertion":[{"value":"24 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.L.W. and S.T. are coinventors and receive royalties from patents owned by University of California San Diego (UCSD) and are cofounders and have equity interests in Oxitope LLC and Kleanthi Diagnostics. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}